We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Adipokines and the Risk of Reflux Esophagitis

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified March 2012 by Donghee Kim, Seoul National University Hospital.
Recruitment status was:  Not yet recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT01560598
First Posted: March 22, 2012
Last Update Posted: March 22, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Donghee Kim, Seoul National University Hospital
March 20, 2012
March 22, 2012
March 22, 2012
June 2012
June 2013   (Final data collection date for primary outcome measure)
Difference in serum adipokine levels between case and control groups [ Time Frame: 2 month lager (after sampling) ]
Same as current
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
Adipokines and the Risk of Reflux Esophagitis
Adipokines and the Risk of Reflux Esophagitis : Prospective Case-control Study
We aimed to risk faoctors for GERD and association between visceral obesity, plasma adipoline(leptin, adiponectin, IL-6, TNF-α)and development of reflux esophagitis in healthy Koreans.
Not Provided
Observational
Observational Model: Case Control
Time Perspective: Prospective
Not Provided
Retention:   Samples Without DNA
Description:
serum
Non-Probability Sample
healthy adults who visit healthcare system for routine checkup
  • Visceral Obesity
  • Reflux Esophagitis
Not Provided
  • Reflux esophagitis
    those with endoscopically proven reflux esophagitis
  • Normal
    those with normal GFS finding (without definite mucosal break at Z-line)
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Unknown status
600
Not Provided
June 2013   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • endoscopically proven reflux esophagitis

Exclusion Criteria:

  • those with esophageal hiatal hernia, current PPI medication, upper GI operation history
Sexes Eligible for Study: All
18 Years to 75 Years   (Adult, Senior)
Yes
Contact information is only displayed when the study is recruiting subjects
Korea, Republic of
 
 
NCT01560598
gerdadipokine
Yes
Not Provided
Not Provided
Donghee Kim, Seoul National University Hospital
Seoul National University Hospital
Not Provided
Not Provided
Seoul National University Hospital
March 2012